Gt Biopharma Inc (GTBP)

May 22, 2026

GT Biopharma, Inc. 8-K Filing: Nasdaq Compliance, Company Details & Key Disclosures (May 20, 2026) 10 - Minichart

May 22, 2026

May 22, 2026

GT Biopharma receives 180-day extension from Nasdaq to meet minimum bid price - Investing.com

May 22, 2026

May 22, 2026

GT Biopharma Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

May 22, 2026

May 22, 2026

Nasdaq grants GT Biopharma (NASDAQ: GTBP) 180-day minimum bid reprieve - Stock Titan

May 22, 2026

May 22, 2026

GTBP Stock Chart | GT BIOPHARMA INC (NASDAQ:GTBP) - ChartMill

May 22, 2026

May 21, 2026

GT Biopharma Edges Higher, Testing Key Resistance at $0.45Community Watchlist Picks - Newser

May 21, 2026

May 21, 2026

GT Biopharma Q1 2026 Earnings: Wider-Than-Expected Loss Amid Strategic Pipeline UpdatesCommunity Exit Signals - Newser

May 21, 2026

May 19, 2026

GT Biopharma Inc stock (US36254L1098): new B7-H3 TriKE enters the clinic and puts NK cell engagers i - AD HOC NEWS

May 19, 2026

May 19, 2026

Exclusive: GT Biopharma begins testing of lead solid tumor drug candidate across multiple cancer types - MSN

May 19, 2026

May 19, 2026

B7-H3 Becomes The Hottest Antigen In Oncology, And One NK Engager Enters Clinic - Sahm

May 19, 2026

May 18, 2026

Why Is GT Biopharma, Inc. (GTBP.PA) Stock Down Today? - Meyka

May 18, 2026

May 17, 2026

GT Biopharma Inc stock (US36254L1098): clinical pipeline and stock under pressure after recent finan - AD HOC NEWS

May 17, 2026

May 16, 2026

Key facts: GT Biopharma Q1 Loss $2.83M; Nasdaq Listing at Risk - TradingView

May 16, 2026

May 15, 2026

GT Biopharma, Inc. Q1 2026 Financial Results: Quarterly Report, Financial Statements, and Key Disclosures - Minichart

May 15, 2026

May 15, 2026

GTBP Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

May 15, 2026

May 15, 2026

GT Biopharma Inc reports results for the quarter ended December 31Earnings Summary - TradingView

May 15, 2026

May 15, 2026

GT Biopharma Reports First Quarter 2026 Financial Results - The Manila Times

May 15, 2026

May 15, 2026

GT Biopharma, Inc. 1Q 2026: Net loss $(2.83M), Revenue $0— 10-Q Summary - TradingView

May 15, 2026

May 15, 2026

GT Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 15, 2026

May 15, 2026

[10-Q] GT Biopharma, Inc. Quarterly Earnings Report - Stock Titan

May 15, 2026

May 15, 2026

GTBP Q1'26 Earnings: EPS estimate is (0.08) USD - TradingView

May 15, 2026

May 14, 2026

First Patient Dosed in Phase 1 Trial Marks Expansion of NK Cell Engager Platform Into Solid Tumors - Baystreet.ca

May 14, 2026

May 14, 2026

"Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies - GlobeNewswire Inc.

May 14, 2026

May 14, 2026

GT Biopharma stock (US36254L1098): First patient dosed in solid tumor trial - AD HOC NEWS

May 14, 2026

May 14, 2026

GT Biopharma Inc - Menafn.com

May 14, 2026

May 14, 2026

A Cancer Antigen Long Thought Untouchable Is Suddenly the Hottest Target in Oncology - Toronto Star

May 14, 2026

May 14, 2026

GT Biopharma announces first patient dosed in phase 1 trial of GTB-5550, a B7-H3-targeted natural killer (NK) cell engager for solid tumors - marketscreener.com

May 14, 2026

May 14, 2026

GT Biopharma doses first patient in solid tumor trial By Investing.com - Investing.com Australia

May 14, 2026

May 14, 2026

GT Biopharma doses first patient in solid tumor trial - Investing.com India

May 14, 2026

May 14, 2026

GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors - The Manila Times

May 14, 2026

May 14, 2026

GT Biopharma Announces First Patient Dosed in Phase 1 Trial - GlobeNewswire

May 14, 2026

May 14, 2026

EXCLUSIVE: GT Biopharma Begins Testing Of Lead Solid Tumor Drug Candidate Across Multiple Cancer Types - Benzinga

May 14, 2026

May 14, 2026

[EFFECT] GT Biopharma, Inc. SEC Filing - Stock Titan

May 14, 2026

May 13, 2026

9.72M GT Biopharma shares registered for resale (NASDAQ: GTBP) - Stock Titan

May 13, 2026

May 12, 2026

MSN Money - MSN

May 12, 2026

May 12, 2026

TradingKey - TradingKey

May 12, 2026

May 11, 2026

| Fierce Healthcare - Fierce Healthcare

May 11, 2026

May 09, 2026

GT Biopharma | UPLOAD: Others - Moomoo

May 09, 2026

May 08, 2026

GT Biopharma Inc stock (US36254L1098): FDA clears IND for NK cell therapy GTB-5550 in solid tumors - AD HOC NEWS

May 08, 2026

May 08, 2026

The critical factors shaping GT Biopharma (GTBP) future (Softens) 2026-05-08Large Cap Trends - Newser

May 08, 2026

Apr 30, 2026

GT Biopharma (NASDAQ: GTBP) registers 9.7M shares for investor resale - Stock Titan

Apr 30, 2026

Apr 30, 2026

Anthony Cataldo Stole $3.2M From GT Biopharma to Fund His Beverly Hills Mansion - hannahhowell.com

Apr 30, 2026

Apr 27, 2026

GTBP Stock Price, Quote & Chart | GT BIOPHARMA INC (NASDAQ:GTBP) - ChartMill

Apr 27, 2026

Apr 20, 2026

Replays from RedChip's Biotech Investor Conference Now Available - ChartMill

Apr 20, 2026

Apr 20, 2026

GT Biopharma (GTBP) Stock All or None (-1.58%) 2026-04-20Social Trading Insights - Newser

Apr 20, 2026

Apr 17, 2026

GTBP | GT Biopharma Inc. Common Insider Trading - Quiver Quantitative

Apr 17, 2026

Apr 15, 2026

GT Biopharma (GTBP) Stock: Volatility Risk (-0.26%) 2026-04-15Income Investing - Newser

Apr 15, 2026